Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Characterization of the in vitro, ex vivo, and in vivo Efficacy of the Antimicrobial Peptide DPK-060 Used for Topical Treatment.
RISE - Research Institutes of Sweden (2017-2019), Biovetenskap och material, Kemi och material.ORCID-id: 0000-0002-4270-8475
RISE - Research Institutes of Sweden (2017-2019), Biovetenskap och material, Kemi och material.
Université de Lorraine, France; Université Bretagne Loire, France.
RISE - Research Institutes of Sweden (2017-2019), Biovetenskap och material, Kemi och material.
Visa övriga samt affilieringar
2019 (Engelska)Ingår i: Frontiers in Cellular and Infection Microbiology, E-ISSN 2235-2988, Vol. 9, artikel-id 174Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Antimicrobial peptides, also known as host defense peptides, have recently emerged as a promising new category of therapeutic agents for the treatment of infectious diseases. This study evaluated the preclinical in vitro, ex vivo, and in vivo antimicrobial activity, as well as the potential to cause skin irritation, of human kininogen-derived antimicrobial peptide DPK-060 in different formulations designed for topical delivery. We found that DPK-060 formulated in acetate buffer or poloxamer gel caused a marked reduction of bacterial counts of Staphylococcus aureus in vitro (minimum microbicidal concentration <5 μg/ml). We also found that DPK-060 in poloxamer gel significantly suppressed microbial survival in an ex vivo wound infection model using pig skin and in an in vivo mouse model of surgical site infection (≥99 or ≥94% reduction in bacterial counts was achieved with 1% DPK-060 at 4 h post-treatment, respectively). Encapsulation of DPK-060 in different types of lipid nanocapsules or cubosomes did not improve the bactericidal potential of the peptide under the applied test conditions. No reduction in cell viability was observed in response to administration of DPK-060 in any of the formulations tested. In conclusion, the present study confirms that DPK-060 has the potential to be an effective and safe drug candidate for the topical treatment of microbial infections; however, adsorption of the peptide to nanocarriers failed to show any additional benefits.

Ort, förlag, år, upplaga, sidor
2019. Vol. 9, artikel-id 174
Nyckelord [en]
DPK-060, antimicrobial peptides, cubosomes, lipid nanocapsules, skin infections
Nationell ämneskategori
Naturvetenskap
Identifikatorer
URN: urn:nbn:se:ri:diva-39066DOI: 10.3389/fcimb.2019.00174PubMedID: 31192163Scopus ID: 2-s2.0-85068146000OAI: oai:DiVA.org:ri-39066DiVA, id: diva2:1331034
Tillgänglig från: 2019-06-26 Skapad: 2019-06-26 Senast uppdaterad: 2020-02-07Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMedScopus

Personposter BETA

Håkansson, JoakimBoge, Lukas

Sök vidare i DiVA

Av författaren/redaktören
Håkansson, JoakimBoge, Lukas
Av organisationen
Kemi och material
I samma tidskrift
Frontiers in Cellular and Infection Microbiology
Naturvetenskap

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 30 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
v. 2.35.10